Author:
Conreur Charlotte,Coureau Michelle,Grimaldi David,Simonet Olivier,Vallot Frédéric,Ndjekembo Shango Didier
Abstract
Abstract
Background
Leptospirosis is known for its pulmonary form characterized by intra-alveolar hemorrhage, exhibiting a high mortality rate. Management by venous–venous extracorporeal membrane oxygenation has been reported in a small number of cases.
Case presentation
We report herein the case of a 16-year-old Caucasian male who was admitted with rapidly deteriorating respiratory and digestive complaints. He developed severe acute respiratory distress syndrome secondary to disseminated intravascular coagulation and intra-alveolar hemorrhage, requiring initiation of venous–venous extracorporeal membrane oxygenation. Initial infectious and immunological assessments were inconclusive, but repeat serology on the tenth day of admission confirmed a diagnosis of leptospirosis. The patient received multiple transfusions, and upon favorable response to treatment with corticosteroids and antibiotics, he was successfully weaned off venous–venous extracorporeal membrane oxygenation, which was discontinued after 12 days.
Conclusion
Leptospirosis is a rare cause of severe acute respiratory failure following pulmonary hemorrhage. It is typically diagnosed by serology, with detectable IgM antibodies 5–7 days after the onset of symptoms. We report that early support with respiratory extracorporeal membrane oxygenation favors timely clearance of endobronchial clotting, parenchymal recovery, and prevention of ventilator-induced lung injury. Major hypofibrinogenemia, which did not seem to worsen during extracorporeal membrane oxygenation application, was managed by repeated transfusions. Further studies investigating the pathogenesis of this coagulopathy are required to further optimize the management of this rare and severe complication.
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Paganin F, Bourdin A, Dalban C, et al. Leptospirosis in Reunion Island (Indian Ocean): analysis of factors associated with severity in 147 confirmed cases. Intensive Care Med. 2007;33(11):1959–66. https://doi.org/10.1007/s00134-007-0776-y.
2. Wirongrong C, Panatsaya T, Yupin S, et al. Activation of the coagulation cascade in patients with leptospirosis. Clin Infect Dis. 2008;46(2):254–60. https://doi.org/10.1086/524664.
3. Nicodemo AC, Duarte-Neto AN. Pathogenesis of pulmonary hemorrhagic syndrome in human leptospirosis. Am J Trop Med Hyg. 2021;104(6):1970–2. https://doi.org/10.4269/ajtmh.20-1000.
4. Fouassier M, Quainon F, Souweine B, et al. Traitement substitutif symptomatique des CIVD (à l’exclusion des antithrombine et proteine C). Réanimation. 2002;11(8):629–37. https://doi.org/10.1016/S1624-0693(02)00310-9.
5. Benjamin D. Leptospirose grave: analyse de la mortalité et des défaillances d’organes chez 134 patients hospitalisés en réanimation à la Réunion. Médecine humaine et pathologie. 2015. dumas-01245128
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献